Association Between Laparoscopic Removal of Endometriomas and Anti-mullerian Hormone Levels
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02685644|
Recruitment Status : Not yet recruiting
First Posted : February 19, 2016
Last Update Posted : February 19, 2016
|Condition or disease||Intervention/treatment|
|Endometriosis Ovarian Reserve||Procedure: Laparoscopic removal of cysts|
|Study Type :||Observational|
|Estimated Enrollment :||102 participants|
|Official Title:||Effects of Laparoscopic Endometrioma Removal on Anti-mullerian Hormone Levels|
|Study Start Date :||April 2016|
|Estimated Primary Completion Date :||September 2018|
|Estimated Study Completion Date :||December 2018|
Patients with endometrioma who will undergo laparoscopic removal of cysts.
Procedure: Laparoscopic removal of cysts
Women with endometrioma lesions will undergo laparoscopic removal. Cysts will be enucleated with blunt dissection of the cyst capsule and following traction, counter traction maneuver. Bipolar coagulation will be used sparsely and suturing will be the predominant choice for achieving bleeding control.
- Anti-Mullerian hormone levels [ Time Frame: 1 year ]AMH (anti-mullerian hormone) levels will be measured before surgery and during various time points up to 1 year after the surgery
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02685644
|Contact: Erkan Kalafatemail@example.com|
|Principal Investigator:||Erkan Kalafat||Ankara University|